Cargando…
Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence
Cardiovascular diseases (CVDs) remain the leading cause of death in the world and in most developed countries. Patients with type 2 diabetes mellitus (T2DM) suffer from both microvascular and macrovascular diseases and therefore have higher rates of morbidity and mortality compared to those without...
Autores principales: | Pozo, Leonardo, Bello, Fatimah, Suarez, Andres, Ochoa-Martinez, Francisco E, Mendez, Yamely, Chang, Chelsea H, Surani, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522760/ https://www.ncbi.nlm.nih.gov/pubmed/31139316 http://dx.doi.org/10.4239/wjd.v10.i5.291 |
Ejemplares similares
-
Cystic fibrosis-related diabetes: The unmet need
por: Pozo, Leonardo, et al.
Publicado: (2020) -
Diabetic ketoacidosis: Treatment in the intensive care unit or general medical/surgical ward?
por: Mendez, Yamely, et al.
Publicado: (2017) -
Ketosis-prone diabetes mellitus: A phenotype that hospitalists need to understand
por: Boike, Sydney, et al.
Publicado: (2022) -
Abdominal compartment syndrome: Often overlooked conditions in medical intensive care units
por: Rajasurya, Venkat, et al.
Publicado: (2020) -
Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic
por: Mendez, Yamely, et al.
Publicado: (2023)